Publication Date:
2015-10-30
Description:
DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis Cell Death and Disease 6, e1955 (October 2015). doi:10.1038/cddis.2015.289 Authors: J Zhou, Z Ning, B Wang, E-J Yun, T Zhang, R-C Pong, L Fazli, M Gleave, J Zeng, J Fan, X Wang, L Li, J-T Hsieh, D He & K Wu
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink